These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17343032)

  • 1. [Contrast media and percutaneous coronary interventions].
    Aubry P; Halna du Fretay X; Tchetche D
    Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):2-9. PubMed ID: 17343032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of X-ray contrast media on hemostasis and its role in the genesis of adverse reactions].
    Sviridov NK; Napolov IuK
    Vestn Rentgenol Radiol; 2001; (2):62-4. PubMed ID: 11503182
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrast media and clotting: what is the evidence?
    Reiner JS
    Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S35-8. PubMed ID: 20333705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
    Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selection of contrast media for hemodynamic studies and limitation of the associated risk].
    Baralis G; Steffenino G; Dellavalle A; La Scala E; Uslenghi E
    Ital Heart J Suppl; 2004 Feb; 5(2):142-50. PubMed ID: 15080534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodinated contrast media and the kidney.
    Weisbord SD
    Rev Cardiovasc Med; 2008; 9 Suppl 1():S14-23. PubMed ID: 18418313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast media: procedural capacities and potential risks.
    Davidson CJ; Erdogan AK
    Rev Cardiovasc Med; 2008; 9 Suppl 1():S24-34. PubMed ID: 18418314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast media-associated nephrotoxicity.
    Rudnick MR; Berns JS; Cohen RM; Goldfarb S
    Semin Nephrol; 1997 Jan; 17(1):15-26. PubMed ID: 9000546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-osmolality versus high-osmolality contrast material.
    Korn WT; Bettmann MA
    Curr Opin Radiol; 1992 Apr; 4(2):9-15. PubMed ID: 1554592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of pharmacologic effects of roentgen contrast media].
    Blaschke TF; Melmon KL
    Internist (Berl); 1974 Aug; 15(8):439-43. PubMed ID: 4140165
    [No Abstract]   [Full Text] [Related]  

  • 11. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology?
    Henry DA; Evans DB; Robertson J
    Med J Aust; 1991 Jun; 154(11):766-72. PubMed ID: 1828529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics and tolerance of roentgen contrast media].
    Schmiedel E
    Rontgenblatter; 1987 Jan; 40(1):1-8. PubMed ID: 3547606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodinated radiographic contrast media: comparison of low-osmolar with conventional ionic agents [corrected].
    Rubin JD; Cohan RH
    Curr Opin Radiol; 1991 Oct; 3(5):637-45. PubMed ID: 1931499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic contrast agents: conventional and new media compared.
    Bettmann MA
    AJR Am J Roentgenol; 1982 Oct; 139(4):787-94. PubMed ID: 6812399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current problems with delayed reactions to intravascular administration of nonionic contrast media].
    Beyer-Enke SA
    Aktuelle Radiol; 1996 Nov; 6(6):330-3. PubMed ID: 9081406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity of low osmolality contrast media versus high osmolality media.
    Steinberg EP; Moore RD; Brinker JA; Fishman EK; Powe NR; Graziano SL; Gopalan R
    Invest Radiol; 1991 Nov; 26 Suppl 1():S86; discussion S88-91. PubMed ID: 1808157
    [No Abstract]   [Full Text] [Related]  

  • 17. [Electron microscopic comparison of the antithrombotic potential of 2 low osmolality iodine contrast media in percutaneous transluminal coronary angioplasty].
    Lefèvre T; Bernard A; Bertrand M; Lablanche JM; Cequier A; Espuglas E; Gayet JL; Gosselin G; Bonan R
    Arch Mal Coeur Vaiss; 1994 Feb; 87(2):225-33. PubMed ID: 7802530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in contrast media and contrast injectors.
    Messenger JC; Casserly IP
    Cardiol Clin; 2009 Aug; 27(3):407-15. PubMed ID: 19573714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions produced by iodinated contrast media.
    Tabar AI; Gamboa PM; García-Delgado F; Oehling A
    Allergol Immunopathol (Madr); 1986; 14(1):71-7. PubMed ID: 2421567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Product selection criteria for intravascular ionic contrast media.
    Swanson DP; Dick TJ; Simms SM; Thrall JH
    Clin Pharm; 1985; 4(5):527-38. PubMed ID: 3902331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.